As the number of immunocompromised patients rise in our hospitals, the presentation of severe infections caused by HSV and CMV are rising. Most importantly, lack of response and documented resistance are becoming more frequently observed.
- The clinical problems caused by resistant HSV and CMV infections.
- Mechanisms of resistance in these organisms.
- Insights into novel therapeutic approaches to treat resistant gonococcal infections.
- Christine M. Johnston, MD, MPH - Associate Professor Department of Medicine, Division of Allergy and Infectious Diseases. Adjunct Associate Professor, Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
- Roy Chemaly, MD, MPH - Professor of Medicine, Chief Infection Control Officer, Director, Clinical Virology Research, University of Texas MD Anderson Cancer Center, Houston, TX.
This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up.
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.
Subscribe to Editors in Conversation (free) on Apple Podcasts, Google Podcasts, Android, Spotify, Email.